EUVIMEDEUVIMED entdecken
Open Access

Participant Engagement and Adherence to Providing Smartwatch and Patient-Reported Outcome Data: Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Real-World Study

William B Nowell iD, Jeffrey R Curtis iD, Hong Zhao iD, Fenglong Xie iD, Laura Stradford iD, David Curtis iD, Kelly Gavigan iD, Jessica Boles iD, Cassie Clinton iD, Ilya Lipkovich iD, Shilpa Venkatachalam iD, Amy Calvin iD und 1 weitere

JMIR Human Factors · 2023

DOI: 10.2196/44034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JMIR Human Factors, 2023. Verfasst von William B Nowell und 12 weiteren Autor:innen. Beteiligte Einrichtung: Global Healthy Living Foundation, Upper Nyack, NY, United States. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Mobile Applications. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Digital health studies using electronic patient-reported outcomes (ePROs) and wearables bring new challenges, including the need for participants to consistently provide trial data.

Objective

This study aims to characterize the engagement, protocol adherence, and data completeness among participants with rheumatoid arthritis enrolled in the Digital Tracking of Arthritis Longitudinally (DIGITAL) study.

Methods

Participants were invited to participate in this app-based study, which included a 14-day run-in and an 84-day main study. In the run-in period, data were collected via the ArthritisPower mobile app to increase app familiarity and identify the individuals who were motivated to participate. Successful completers of the run-in period were mailed a wearable smartwatch, and automated and manual prompts were sent to participants, reminding them to complete app input or regularly wear and synchronize devices, respectively, during the main study. Study coordinators monitored participant data and contacted participants via email, SMS text messaging, and phone to resolve adherence issues per a priori rules, in which consecutive spans of missing data triggered participant contact. Adherence to data collection during the main study period was defined as providing requested data for >70% of 84 days (daily ePRO, ≥80% daily smartwatch data) or at least 9 of 12 weeks (weekly ePRO).

Results

Of the 470 participants expressing initial interest, 278 (59.1%) completed the run-in period and qualified for the main study. Over the 12-week main study period, 87.4% (243/278) of participants met the definition of adherence to protocol-specified data collection for weekly ePRO, and 57.2% (159/278) did so for daily ePRO. For smartwatch data, 81.7% (227/278) of the participants adhered to the protocol-specified data collection. In total, 52.9% (147/278) of the participants met composite adherence.

Conclusions

Compared with other digital health rheumatoid arthritis studies, a short run-in period appears useful for identifying participants likely to engage in a study that collects data via a mobile app and wearables and gives participants time to acclimate to study requirements. Automated or manual prompts (ie, “It’s time to sync your smartwatch”) may be necessary to optimize adherence. Adherence varies by data collection type (eg, ePRO vs smartwatch data). International Registered Report Identifier (IRRID) RR2-10.2196/14665

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidMobile ApplicationsHumansData CollectionElectronic MailPatient Reported Outcome Measures

Stichwörter der Autor:innen

mobile phonemobile technologypatient-generated health datapatient-reported outcomespatientsreal-world datareal-world evidencerheumatoid arthritiswearable digital technology

Autor:innen und Institutionen

  • Global Healthy Living Foundation, Upper Nyack, NY, United States.
  • University of Alabama at Birmingham, Birmingham, AL, United States.
  • Kirklin Solutions, Hoover, AL, United States.
  • C3i Solutions HCL, Horsham, PA, United States.
  • Eli Lilly and Company, Indianapolis, IN, United States.
  • Medidata Solutions, Inc, New York, NY, United States.

ORCID-Profile: William B Nowell, Jeffrey R Curtis, Hong Zhao, Fenglong Xie, Laura Stradford, David Curtis, Kelly Gavigan, Jessica Boles, Cassie Clinton, Ilya Lipkovich, Shilpa Venkatachalam, Amy Calvin, Virginia S Hayes

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Nowell, W. B., Curtis, J. R., Zhao, H., Xie, F., Stradford, L., Curtis, D., Gavigan, K., Boles, J., Clinton, C., Lipkovich, I., Venkatachalam, S., Calvin, A., & Hayes, V. S. (2023). Participant Engagement and Adherence to Providing Smartwatch and Patient-Reported Outcome Data: Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Real-World Study. JMIR Human Factors. https://doi.org/10.2196/44034

Vancouver

Nowell WB, Curtis JR, Zhao H, Xie F, Stradford L, Curtis D, et al. Participant Engagement and Adherence to Providing Smartwatch and Patient-Reported Outcome Data: Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Real-World Study. JMIR Human Factors. 2023. doi:10.2196/44034

BibTeX
@article{Nowell2023,
  author = {Nowell, William B and Curtis, Jeffrey R and Zhao, Hong and Xie, Fenglong and Stradford, Laura and Curtis, David and Gavigan, Kelly and Boles, Jessica and Clinton, Cassie and Lipkovich, Ilya and Venkatachalam, Shilpa and Calvin, Amy and Hayes, Virginia S},
  title = {Participant Engagement and Adherence to Providing Smartwatch and Patient-Reported Outcome Data: Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Real-World Study},
  journal = {JMIR Human Factors},
  year = {2023},
  doi = {10.2196/44034}
}
Kostenlos starten →